NRT smoking cessation aids is set to see sales fall in 2023. The category has been adversely affected by new regulations relating to other NRT introduced in May 2023. Nicotine pouches, which were previously only sold as OTC medicine, were announced to no longer be considered as OTC medicine by the Finnish Medicine Agency. This meant that such products could now be sold under tobacco product legislation, though, as of mid-2023, the sales situation remained unclear.
The analyst's NRT Smoking Cessation Aids in Finland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.
Product coverage:
NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage:
Market sizes (historic and forecasts), company shares, brand shares and distribution data.
The analyst's NRT Smoking Cessation Aids in Finland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.
Product coverage:
NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage:
Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the NRT Smoking Cessation Aids market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
NRT SMOKING CESSATION AIDS IN FINLANDKEY DATA FINDINGSCONSUMER HEALTH IN FINLANDDISCLAIMERDEFINITIONS
2023 DEVELOPMENTS
PROSPECTS AND OPPORTUNITIES
CATEGORY DATA
EXECUTIVE SUMMARY
MARKET INDICATORS
MARKET DATA
APPENDIX
SOURCES